{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:52:01Z","timestamp":1788846721166,"version":"build-2803163510"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92049102"],"award-info":[{"award-number":["92049102"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222113"],"award-info":[{"award-number":["7222113"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12035-023-03801-1","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T23:30:34Z","timestamp":1701214234000},"page":"3836-3850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clusterin is a Potential Therapeutic Target in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"61","author":[{"given":"Nazhakaiti","family":"Palihati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-4460","authenticated-orcid":false,"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"3801_CR1","doi-asserted-by":"publisher","unstructured":"Foster EM, Dangla-Valls A, Lovestone S et al (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13. https:\/\/doi.org\/10.3389\/fnins.2019.00164","DOI":"10.3389\/fnins.2019.00164"},{"key":"3801_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F (2022) Gene\u2013environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol 18:643\u2013660. https:\/\/doi.org\/10.1038\/s41582-022-00714-w","journal-title":"Nat Rev Neurol"},{"key":"3801_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer\u2019s disease. The Lancet 397:1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"The Lancet"},{"key":"3801_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu C-C et al (2022) ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110:1304\u20131317. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","journal-title":"Neuron"},{"key":"3801_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 18:421\u2013430. https:\/\/doi.org\/10.1038\/gim.2015.117","journal-title":"Genet Med"},{"key":"3801_CR6","doi-asserted-by":"publisher","first-page":"15132","DOI":"10.18632\/oncotarget.23738","volume":"9","author":"M-H Dai","year":"2017","unstructured":"Dai M-H, Zheng H, Zeng L-D, Zhang Y (2017) The genes associated with early-onset Alzheimer\u2019s disease. Oncotarget 9:15132\u201315143. https:\/\/doi.org\/10.18632\/oncotarget.23738","journal-title":"Oncotarget"},{"key":"3801_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease, and shows evidence for additional susceptibility genes. Nat Genet 41:1088\u20131093. https:\/\/doi.org\/10.1038\/ng.440","journal-title":"Nat Genet"},{"key":"3801_CR8","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Arfan Ikram M et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer\u2019s disease. JAMA 303:1832\u20131840. https:\/\/doi.org\/10.1001\/jama.2010.574","journal-title":"JAMA"},{"key":"3801_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0003-9969(79)90040-2","volume":"24","author":"SD Hogg","year":"1979","unstructured":"Hogg SD, Embery G (1979) The isolation and partial characterization of a sulphated glycoprotein from human whole saliva which aggregates strains of Streptococcus sanguis but not Streptococcus mutans. Arch Oral Biol 24:791\u2013797. https:\/\/doi.org\/10.1016\/0003-9969(79)90040-2","journal-title":"Arch Oral Biol"},{"key":"3801_CR10","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1074\/jbc.274.11.6875","volume":"274","author":"DT Humphreys","year":"1999","unstructured":"Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR (1999) Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 274:6875\u20136881. https:\/\/doi.org\/10.1074\/jbc.274.11.6875","journal-title":"J Biol Chem"},{"key":"3801_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099. https:\/\/doi.org\/10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"3801_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fnagi.2016.00179","volume":"8","author":"R Cai","year":"2016","unstructured":"Cai R, Han J, Sun J et al (2016) Plasma clusterin and the CLU gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients. Front Aging Neurosci 8:179. https:\/\/doi.org\/10.3389\/fnagi.2016.00179","journal-title":"Front Aging Neurosci"},{"key":"3801_CR13","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1093\/hmg\/ddx329","volume":"26","author":"B Padhy","year":"2017","unstructured":"Padhy B, Hayat B, Nanda GG et al (2017) Pseudoexfoliation and Alzheimer\u2019s associated CLU risk variant, rs2279590, lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression. Hum Mol Genet 26:4519\u20134529. https:\/\/doi.org\/10.1093\/hmg\/ddx329","journal-title":"Hum Mol Genet"},{"key":"3801_CR14","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"3801_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM (2015) Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77:43\u201351. https:\/\/doi.org\/10.1016\/j.biopsych.2014.05.006","journal-title":"Biol Psychiatry"},{"key":"3801_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1326-7-3","volume":"7","author":"K Bettens","year":"2012","unstructured":"Bettens K, Brouwers N, Engelborghs S et al (2012) Both common variations and rare non-synonymous substitutions and small insertion\/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener 7:3. https:\/\/doi.org\/10.1186\/1750-1326-7-3","journal-title":"Mol Neurodegener"},{"key":"3801_CR17","doi-asserted-by":"publisher","unstructured":"Rizzi F, Coletta M, Bettuzzi S (2009) Chapter 2 Clusterin (CLU): from one gene and two transcripts to many proteins. In: Advances in Cancer Research. Academic Press, 9\u201323.https:\/\/doi.org\/10.1016\/S0065-230X(09)04002-0","DOI":"10.1016\/S0065-230X(09)04002-0"},{"key":"3801_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/bmc-2015-0026","volume":"7","author":"P Rohne","year":"2016","unstructured":"Rohne P, Prochnow H, Koch-Brandt C (2016) The CLU-files: disentanglement of a mystery. Biomol Concepts 7:1\u201315. https:\/\/doi.org\/10.1515\/bmc-2015-0026","journal-title":"Biomol Concepts"},{"key":"3801_CR19","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.tibs.2021.01.005","volume":"46","author":"S Satapathy","year":"2021","unstructured":"Satapathy S, Wilson MR (2021) The dual roles of clusterin in extracellular and intracellular proteostasis. Trends Biochem Sci 46:652\u2013660. https:\/\/doi.org\/10.1016\/j.tibs.2021.01.005","journal-title":"Trends Biochem Sci"},{"key":"3801_CR20","doi-asserted-by":"publisher","first-page":"166384","DOI":"10.1016\/j.bbadis.2022.166384","volume":"1868","author":"PM Spatharas","year":"2022","unstructured":"Spatharas PM, Nasi GI, Tsiolaki PL et al (2022) Clusterin in Alzheimer\u2019s disease an amyloidogenic inhibitor of amyloid formation? Biochimica et Biophysica Acta (BBA) - Mole Basis Dis 1868:166384. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166384","journal-title":"Biochimica et Biophysica Acta (BBA) - Mole Basis Dis"},{"key":"3801_CR21","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.1021\/bi010135x","volume":"40","author":"RW Bailey","year":"2001","unstructured":"Bailey RW, Dunker AK, Brown CJ et al (2001) Clusterin, a binding protein with a molten globule-like region. Biochemistry 40:11828\u201311840. https:\/\/doi.org\/10.1021\/bi010135x","journal-title":"Biochemistry"},{"key":"3801_CR22","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M209233200","volume":"278","author":"KS Leskov","year":"2003","unstructured":"Leskov KS, Klokov DY, Li J et al (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein*. J Biol Chem 278:11590\u201311600. https:\/\/doi.org\/10.1074\/jbc.M209233200","journal-title":"J Biol Chem"},{"key":"3801_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.cdd.4401491","volume":"12","author":"AE Caccamo","year":"2005","unstructured":"Caccamo AE, Scaltriti M, Caporali A et al (2005) Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells. Cell Death Differ 12:101\u2013104. https:\/\/doi.org\/10.1038\/sj.cdd.4401491","journal-title":"Cell Death Differ"},{"key":"3801_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-017-0481-1","volume":"5","author":"JM Gregory","year":"2017","unstructured":"Gregory JM, Whiten DR, Brown RA et al (2017) Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol Commun 5:81. https:\/\/doi.org\/10.1186\/s40478-017-0481-1","journal-title":"Acta Neuropathol Commun"},{"key":"3801_CR25","doi-asserted-by":"publisher","first-page":"13240","DOI":"10.1016\/S0021-9258(19)38290-0","volume":"265","author":"HV de Silva","year":"1990","unstructured":"de Silva HV, Stuart WD, Duvic CR et al (1990) A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem 265:13240\u201313247","journal-title":"J Biol Chem"},{"key":"3801_CR26","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.4049\/jimmunol.1500747","volume":"196","author":"GH Hong","year":"2016","unstructured":"Hong GH, Kwon H-S, Moon K-A et al (2016) Clusterin modulates allergic airway inflammation by attenuating CCL20-mediated dendritic cell recruitment. J Immunol 196:2021\u20132030. https:\/\/doi.org\/10.4049\/jimmunol.1500747","journal-title":"J Immunol"},{"key":"3801_CR27","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.4049\/jimmunol.151.4.2159","volume":"151","author":"J Tschopp","year":"1993","unstructured":"Tschopp J, Chonn A, Hertig S, French LE (1993) Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol 151:2159\u20132165","journal-title":"J Immunol"},{"key":"3801_CR28","first-page":"177","volume":"80","author":"A V\u00e4kev\u00e4","year":"1993","unstructured":"V\u00e4kev\u00e4 A, Laurila P, Meri S (1993) Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Immunology 80:177\u2013182","journal-title":"Immunology"},{"key":"3801_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.brainresbull.2012.05.006","volume":"88","author":"Y Charnay","year":"2012","unstructured":"Charnay Y, Imhof A, Vallet PG et al (2012) Clusterin in neurological disorders: molecular perspectives and clinical relevance. Brain Res Bull 88:434\u2013443. https:\/\/doi.org\/10.1016\/j.brainresbull.2012.05.006","journal-title":"Brain Res Bull"},{"key":"3801_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1432-1033.1994.tb18807.x","volume":"221","author":"P Wong","year":"1994","unstructured":"Wong P, Taillefer D, Lakins J et al (1994) Molecular characterization of human TRPM-2\/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 221:917\u2013925. https:\/\/doi.org\/10.1111\/j.1432-1033.1994.tb18807.x","journal-title":"Eur J Biochem"},{"key":"3801_CR31","doi-asserted-by":"publisher","first-page":"111174","DOI":"10.1016\/j.biopha.2020.111174","volume":"134","author":"C Rodr\u00edguez-Rivera","year":"2021","unstructured":"Rodr\u00edguez-Rivera C, Garcia MM, Molina-\u00c1lvarez M et al (2021) Clusterin: always protecting. Synthesis, function and potential issues. Biomed Pharmacother 134:111174. https:\/\/doi.org\/10.1016\/j.biopha.2020.111174","journal-title":"Biomed Pharmacother"},{"key":"3801_CR32","doi-asserted-by":"publisher","first-page":"H2193","DOI":"10.1152\/ajpheart.00355.2005","volume":"289","author":"PAJ Krijnen","year":"2005","unstructured":"Krijnen PAJ, Cillessen SAGM, Manoe R et al (2005) Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol-Heart Circ Physiol 289:H2193\u2013H2202. https:\/\/doi.org\/10.1152\/ajpheart.00355.2005","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"3801_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-biochem-072711-163904","volume":"82","author":"AR Wyatt","year":"2013","unstructured":"Wyatt AR, Yerbury JJ, Ecroyd H, Wilson MR (2013) Extracellular chaperones and proteostasis. Annu Rev Biochem 82:295\u2013322. https:\/\/doi.org\/10.1146\/annurev-biochem-072711-163904","journal-title":"Annu Rev Biochem"},{"key":"3801_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41582-023-00786-2","volume":"19","author":"MR Wilson","year":"2023","unstructured":"Wilson MR, Satapathy S, Vendruscolo M (2023) Extracellular protein homeostasis in neurodegenerative diseases. Nat Rev Neurol 19:235\u2013245. https:\/\/doi.org\/10.1038\/s41582-023-00786-2","journal-title":"Nat Rev Neurol"},{"key":"3801_CR35","doi-asserted-by":"publisher","first-page":"e1305","DOI":"10.1002\/ctm2.1305","volume":"13","author":"MR Wilson","year":"2023","unstructured":"Wilson MR, Satapathy S, Vendruscolo M (2023) Extracellular protein homeostasis: the dawning of a new age for human disease therapies? Clin Transl Med 13:e1305. https:\/\/doi.org\/10.1002\/ctm2.1305","journal-title":"Clin Transl Med"},{"key":"3801_CR36","doi-asserted-by":"publisher","first-page":"39532","DOI":"10.1074\/jbc.M204855200","volume":"277","author":"S Poon","year":"2002","unstructured":"Poon S, Rybchyn MS, Easterbrook-Smith SB et al (2002) Mildly acidic pH activates the extracellular molecular chaperone clusterin*. J Biol Chem 277:39532\u201339540. https:\/\/doi.org\/10.1074\/jbc.M204855200","journal-title":"J Biol Chem"},{"key":"3801_CR37","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/MCB.22.6.1893-1902.2002","volume":"22","author":"ME Rosenberg","year":"2002","unstructured":"Rosenberg ME, Girton R, Finkel D et al (2002) Apolipoprotein J\/clusterin prevents a progressive glomerulopathy of aging. Mol Cell Biol 22:1893\u20131902. https:\/\/doi.org\/10.1128\/MCB.22.6.1893-1902.2002","journal-title":"Mol Cell Biol"},{"key":"3801_CR38","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1600-0854.2007.00549.x","volume":"8","author":"P Nizard","year":"2007","unstructured":"Nizard P, Tetley S, Le Dr\u00e9an Y et al (2007) Stress-induced retrotranslocation of clusterin\/ApoJ into the Cytosol. Traffic 8:554\u2013565. https:\/\/doi.org\/10.1111\/j.1600-0854.2007.00549.x","journal-title":"Traffic"},{"key":"3801_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.tibs.2017.09.002","volume":"42","author":"YT Kwon","year":"2017","unstructured":"Kwon YT, Ciechanover A (2017) The ubiquitin code in the ubiquitin-proteasome system and autophagy. Trends Biochem Sci 42:873\u2013886. https:\/\/doi.org\/10.1016\/j.tibs.2017.09.002","journal-title":"Trends Biochem Sci"},{"key":"3801_CR40","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1038\/ncomms6775","volume":"5","author":"F Zhang","year":"2014","unstructured":"Zhang F, Kumano M, Beraldi E et al (2014) Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival. Nat Commun 5:5775. https:\/\/doi.org\/10.1038\/ncomms6775","journal-title":"Nat Commun"},{"key":"3801_CR41","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1007\/s00018-011-0684-8","volume":"68","author":"AR Wyatt","year":"2011","unstructured":"Wyatt AR, Yerbury JJ, Berghofer P et al (2011) Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell Mol Life Sci 68:3919\u20133931. https:\/\/doi.org\/10.1007\/s00018-011-0684-8","journal-title":"Cell Mol Life Sci"},{"key":"3801_CR42","doi-asserted-by":"publisher","first-page":"14425","DOI":"10.1074\/jbc.M117.786657","volume":"292","author":"P Constantinescu","year":"2017","unstructured":"Constantinescu P, Brown RA, Wyatt AR et al (2017) Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones. J Biol Chem 292:14425\u201314437. https:\/\/doi.org\/10.1074\/jbc.M117.786657","journal-title":"J Biol Chem"},{"key":"3801_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","volume":"127","author":"M Riwanto","year":"2013","unstructured":"Riwanto M, Rohrer L, Roschitzki B et al (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease. Circulation 127:891\u2013904. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.108753","journal-title":"Circulation"},{"key":"3801_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/01.ATV.18.4.665","volume":"18","author":"Y Ishikawa","year":"1998","unstructured":"Ishikawa Y, Akasaka Y, Ishii T et al (1998) Distribution and synthesis of apolipoprotein J in the Atherosclerotic Aorta. Arterioscler Thromb Vasc Biol 18:665\u2013672. https:\/\/doi.org\/10.1161\/01.ATV.18.4.665","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3801_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/01.CIR.101.4.352","volume":"101","author":"C Urbich","year":"2000","unstructured":"Urbich C, Fritzenwanger M, Zeiher AM, Dimmeler S (2000) Laminar shear stress upregulates the complement-inhibitory protein clusterin. Circulation 101:352\u2013355. https:\/\/doi.org\/10.1161\/01.CIR.101.4.352","journal-title":"Circulation"},{"key":"3801_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.legalmed.2005.08.009","volume":"8","author":"T Ishikawa","year":"2006","unstructured":"Ishikawa T, Zhu B-L, Li D-R et al (2006) Age-dependent increase of clusterin in the human pituitary gland. Leg Med (Tokyo) 8:28\u201333. https:\/\/doi.org\/10.1016\/j.legalmed.2005.08.009","journal-title":"Leg Med (Tokyo)"},{"key":"3801_CR47","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/cdd.2010.169","volume":"18","author":"O Cordero-Llana","year":"2011","unstructured":"Cordero-Llana O, Scott SA, Maslen SL et al (2011) Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells. Cell Death Differ 18:907\u2013913. https:\/\/doi.org\/10.1038\/cdd.2010.169","journal-title":"Cell Death Differ"},{"key":"3801_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-020-00416-1","volume":"15","author":"AM Wojtas","year":"2020","unstructured":"Wojtas AM, Sens JP, Kang SS et al (2020) CLU-A\u03b2 astrocyte-derived clusterin suppresses amyloid formation in vivo. Mol Neurodegener 15:71. https:\/\/doi.org\/10.1186\/s13024-020-00416-1","journal-title":"Mol Neurodegener"},{"key":"3801_CR49","doi-asserted-by":"publisher","unstructured":"Chen F, Swartzlander DB, Ghosh A et al (2021) Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer\u2019s disease neuropathology. Mole Neurodegen 16. https:\/\/doi.org\/10.1186\/s13024-021-00426-7","DOI":"10.1186\/s13024-021-00426-7"},{"key":"3801_CR50","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9:a028035. https:\/\/doi.org\/10.1101\/cshperspect.a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3801_CR51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","volume":"34","author":"AA Davis","year":"2018","unstructured":"Davis AA, Leyns CEG, Holtzman DM (2018) Intercellular spread of protein aggregates in neurodegenerative disease. Annu Rev Cell Dev Biol 34:545\u2013568. https:\/\/doi.org\/10.1146\/annurev-cellbio-100617-062636","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3801_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"RM Meade","year":"2019","unstructured":"Meade RM, Fairlie DP, Mason JM (2019) Alpha-synuclein structure and Parkinson\u2019s disease \u2013 lessons and emerging principles. Mol Neurodegener 14:29. https:\/\/doi.org\/10.1186\/s13024-019-0329-1","journal-title":"Mol Neurodegener"},{"key":"3801_CR53","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.3390\/ijms21197181","volume":"21","author":"C Lenzi","year":"2020","unstructured":"Lenzi C, Ramazzina I, Russo I et al (2020) The down-regulation of clusterin expression enhances the \u03b1Synuclein aggregation process. Int J Mol Sci 21:7181. https:\/\/doi.org\/10.3390\/ijms21197181","journal-title":"Int J Mol Sci"},{"key":"3801_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00401-002-0546-4","volume":"104","author":"K Sasaki","year":"2002","unstructured":"Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T (2002) Clusterin\/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with \u03b1-synucleinopathies. Acta Neuropathol 104:225\u2013230. https:\/\/doi.org\/10.1007\/s00401-002-0546-4","journal-title":"Acta Neuropathol"},{"key":"3801_CR55","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/antiox11030524","volume":"11","author":"I Berdowska","year":"2022","unstructured":"Berdowska I, Matusiewicz M, Krzystek-Korpacka M (2022) CLU HDL accessory proteins in Parkinson\u2019s disease\u2014focusing on clusterin (Apolipoprotein J) in regard to its involvement in pathology and diagnostics\u2014a review. Antioxidants (Basel) 11:524. https:\/\/doi.org\/10.3390\/antiox11030524","journal-title":"Antioxidants (Basel)"},{"key":"3801_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R et al (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8:248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther"},{"key":"3801_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s004410100431","volume":"306","author":"L Klimaschewski","year":"2001","unstructured":"Klimaschewski L, Oberm\u00fcller N, Witzgall R (2001) Regulation of clusterin expression following spinal cord injury. Cell Tissue Res 306:209\u2013216. https:\/\/doi.org\/10.1007\/s004410100431","journal-title":"Cell Tissue Res"},{"key":"3801_CR58","doi-asserted-by":"publisher","first-page":"e48255","DOI":"10.7554\/eLife.48255","volume":"8","author":"SK Herring","year":"2019","unstructured":"Herring SK, Moon H-J, Rawal P et al (2019) Brain clusterin protein isoforms and mitochondrial localization. eLife 8:e48255. https:\/\/doi.org\/10.7554\/eLife.48255","journal-title":"eLife"},{"key":"3801_CR59","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1042\/bj3160671","volume":"316","author":"E Matsubara","year":"1996","unstructured":"Matsubara E, Soto C, Governale S et al (1996) Apolipoprotein J and Alzheimer\u2019s amyloid beta solubility. Biochem J 316:671\u2013679","journal-title":"Biochem J"},{"key":"3801_CR60","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1046\/j.1471-4159.1996.67031324.x","volume":"67","author":"LN Boggs","year":"1996","unstructured":"Boggs LN, Fuson KS, Baez M et al (1996) Clusterin (Apo J) Protects against in vitro amyloid-\u03b2(1\u201340) neurotoxicity. J Neurochem 67:1324\u20131327. https:\/\/doi.org\/10.1046\/j.1471-4159.1996.67031324.x","journal-title":"J Neurochem"},{"key":"3801_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1995.1080","volume":"136","author":"T Oda","year":"1995","unstructured":"Oda T, Wals P, Osterburg HH et al (1995) Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1\u201342) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol 136:22\u201331. https:\/\/doi.org\/10.1006\/exnr.1995.1080","journal-title":"Exp Neurol"},{"key":"3801_CR62","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1074\/jbc.M115.689539","volume":"291","author":"M Beeg","year":"2016","unstructured":"Beeg M, Stravalaci M, Romeo M et al (2016) Clusterin binds to A\u03b21\u201342 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and secondary nucleation. J Biol Chem 291:6958\u20136966. https:\/\/doi.org\/10.1074\/jbc.M115.689539","journal-title":"J Biol Chem"},{"key":"3801_CR63","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, O\u2019dell MA, Parsadanian M et al (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 99:10843\u201310848. https:\/\/doi.org\/10.1073\/pnas.162228299","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3801_CR64","doi-asserted-by":"publisher","first-page":"31374","DOI":"10.1074\/jbc.M400348200","volume":"279","author":"M Bucciantini","year":"2004","unstructured":"Bucciantini M, Calloni G, Chiti F et al (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity*. J Biol Chem 279:31374\u201331382. https:\/\/doi.org\/10.1074\/jbc.M400348200","journal-title":"J Biol Chem"},{"key":"3801_CR65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333\u2013366. https:\/\/doi.org\/10.1146\/annurev.biochem.75.101304.123901","journal-title":"Annu Rev Biochem"},{"key":"3801_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nsmb.2191","volume":"19","author":"P Narayan","year":"2011","unstructured":"Narayan P, Orte A, Clarke RW et al (2011) The extracellular chaperone clusterin sequesters oligomeric forms of the A\u03b21\u201340 peptide. Nat Struct Mol Biol 19:79\u201383. https:\/\/doi.org\/10.1038\/nsmb.2191","journal-title":"Nat Struct Mol Biol"},{"key":"3801_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1039\/b712728f","volume":"4","author":"MR Wilson","year":"2008","unstructured":"Wilson MR, Yerbury JJ, Poon S (2008) Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. Mol Biosyst 4:42\u201352. https:\/\/doi.org\/10.1039\/b712728f","journal-title":"Mol Biosyst"},{"key":"3801_CR68","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/sj.embor.7400586","volume":"6","author":"JJ Yerbury","year":"2005","unstructured":"Yerbury JJ, Stewart EM, Wyatt AR, Wilson MR (2005) Quality control of protein folding in extracellular space. EMBO Rep 6:1131\u20131136. https:\/\/doi.org\/10.1038\/sj.embor.7400586","journal-title":"EMBO Rep"},{"key":"3801_CR69","doi-asserted-by":"publisher","first-page":"18644","DOI":"10.1074\/jbc.272.30.18644","volume":"272","author":"SM Hammad","year":"1997","unstructured":"Hammad SM, Ranganathan S, Loukinova E et al (1997) Interaction of Apolipoprotein J-Amyloid \u03b2-peptide complex with low density lipoprotein receptor-related protein-2\/Megalin: a mechanism to prevent pathological accumulation of amyloid \u03b2-peptide*. J Biol Chem 272:18644\u201318649. https:\/\/doi.org\/10.1074\/jbc.272.30.18644","journal-title":"J Biol Chem"},{"key":"3801_CR70","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","volume":"93","author":"BV Zlokovic","year":"1996","unstructured":"Zlokovic BV, Martel CL, Matsubara E et al (1996) Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci U S A 93:4229\u20134234","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3801_CR71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M et al (2004) ApoE and clusterin cooperatively suppress A\u03b2 levels and deposition: evidence that ApoE regulates extracellular A\u03b2 metabolism in vivo. Neuron 41:193\u2013202. https:\/\/doi.org\/10.1016\/S0896-6273(03)00850-X","journal-title":"Neuron"},{"key":"3801_CR72","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD, Sagare AP, Friedman AE et al (2007) Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27:909\u2013918. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600419","journal-title":"J Cereb Blood Flow Metab"},{"key":"3801_CR73","doi-asserted-by":"publisher","first-page":"e201911126","DOI":"10.1083\/jcb.201911126","volume":"219","author":"E Itakura","year":"2020","unstructured":"Itakura E, Chiba M, Murata T, Matsuura A (2020) Heparan sulfate is a clearance receptor for aberrant extracellular proteins. J Cell Biol 219:e201911126. https:\/\/doi.org\/10.1083\/jcb.201911126","journal-title":"J Cell Biol"},{"key":"3801_CR74","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I et al (2016) TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91:328\u2013340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015","journal-title":"Neuron"},{"key":"3801_CR75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","volume":"24","author":"AN Brandebura","year":"2023","unstructured":"Brandebura AN, Paumier A, Onur TS, Allen NJ (2023) Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci 24:23\u201339. https:\/\/doi.org\/10.1038\/s41583-022-00641-1","journal-title":"Nat Rev Neurosci"},{"key":"3801_CR76","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.it.2020.07.004","volume":"41","author":"MV Sofroniew","year":"2020","unstructured":"Sofroniew MV (2020) Astrocyte reactivity: subtypes, states and functions in CNS innate immunity. Trends Immunol 41:758\u2013770. https:\/\/doi.org\/10.1016\/j.it.2020.07.004","journal-title":"Trends Immunol"},{"key":"3801_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","volume":"25","author":"SF Carter","year":"2019","unstructured":"Carter SF, Herholz K, Rosa-Neto P et al (2019) Astrocyte biomarkers in Alzheimer\u2019s disease. Trends Mol Med 25:77\u201395. https:\/\/doi.org\/10.1016\/j.molmed.2018.11.006","journal-title":"Trends Mol Med"},{"key":"3801_CR78","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1006\/bbrc.1994.2580","volume":"204","author":"T Oda","year":"1994","unstructured":"Oda T, Pasinetti GM, Osterburg HH et al (1994) Purification and characterization of brain clusterin. Biochem Biophys Res Commun 204:1131\u20131136. https:\/\/doi.org\/10.1006\/bbrc.1994.2580","journal-title":"Biochem Biophys Res Commun"},{"key":"3801_CR79","doi-asserted-by":"publisher","unstructured":"Wojtas AM, Kang SS, Olley BM et al (2017) Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc Natl Acad Sci USA 114. https:\/\/doi.org\/10.1073\/pnas.1701137114","DOI":"10.1073\/pnas.1701137114"},{"key":"3801_CR80","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/mp.2012.163","volume":"19","author":"R Killick","year":"2014","unstructured":"Killick R, Ribe EM, Al-Shawi R et al (2014) Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt\u2013PCP\u2013JNK pathway. Mol Psychiatry 19:88\u201398. https:\/\/doi.org\/10.1038\/mp.2012.163","journal-title":"Mol Psychiatry"},{"key":"3801_CR81","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1523\/JNEUROSCI.4562-11.2012","volume":"32","author":"SA Purro","year":"2012","unstructured":"Purro SA, Dickins EM, Salinas PC (2012) The secreted Wnt antagonist Dickkopf-1 is required for amyloid \u03b2-mediated synaptic loss. J Neurosci 32:3492\u20133498. https:\/\/doi.org\/10.1523\/JNEUROSCI.4562-11.2012","journal-title":"J Neurosci"},{"key":"3801_CR82","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12:719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheimers Dement"},{"key":"3801_CR83","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2249.2006.03135.x","volume":"145","author":"AK Chauhan","year":"2006","unstructured":"Chauhan AK, Moore TL (2006) Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC). Clin Exp Immunol 145:398\u2013406. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03135.x","journal-title":"Clin Exp Immunol"},{"key":"3801_CR84","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.15252\/embj.201591881","volume":"34","author":"G Bajic","year":"2015","unstructured":"Bajic G, Degn SE, Thiel S, Andersen GR (2015) Complement activation, regulation, and molecular basis for complement-related diseases. Embo J 34:2735\u20132757. https:\/\/doi.org\/10.15252\/embj.201591881","journal-title":"Embo J"},{"key":"3801_CR85","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneph.2016.70","volume":"12","author":"D Ricklin","year":"2016","unstructured":"Ricklin D, Reis ES, Lambris JD (2016) Complement in disease: a defence system turning offensive. Nat Rev Nephrol 12:383\u2013401. https:\/\/doi.org\/10.1038\/nrneph.2016.70","journal-title":"Nat Rev Nephrol"},{"key":"3801_CR86","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s41467-018-03566-5","volume":"9","author":"L Weinhard","year":"2018","unstructured":"Weinhard L, di Bartolomei G, Bolasco G et al (2018) Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat Commun 9:1228. https:\/\/doi.org\/10.1038\/s41467-018-03566-5","journal-title":"Nat Commun"},{"key":"3801_CR87","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE et al (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131:1164\u20131178. https:\/\/doi.org\/10.1016\/j.cell.2007.10.036","journal-title":"Cell"},{"key":"3801_CR88","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan AH, Barres BA, Stevens B (2012) The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 35:369\u2013389. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113810","journal-title":"Annu Rev Neurosci"},{"key":"3801_CR89","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352:712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"key":"3801_CR90","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481\u2013487. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"key":"3801_CR91","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"A Ittner","year":"2018","unstructured":"Ittner A, Ittner LM (2018) Dendritic tau in Alzheimer\u2019s disease. Neuron 99:13\u201327. https:\/\/doi.org\/10.1016\/j.neuron.2018.06.003","journal-title":"Neuron"},{"key":"3801_CR92","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40265-015-0529-0","volume":"76","author":"L Bakota","year":"2016","unstructured":"Bakota L, Brandt R (2016) Tau biology and tau-directed therapies for Alzheimer\u2019s disease. Drugs 76:301\u2013313. https:\/\/doi.org\/10.1007\/s40265-015-0529-0","journal-title":"Drugs"},{"key":"3801_CR93","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2017.07.070","volume":"139","author":"M Jouanne","year":"2017","unstructured":"Jouanne M, Rault S, Voisin-Chiret A-S (2017) Tau protein aggregation in Alzheimer\u2019s disease: an attractive target for the development of novel therapeutic agents. Eur J Med Chem 139:153\u2013167. https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.070","journal-title":"Eur J Med Chem"},{"key":"3801_CR94","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41594-018-0057-1","volume":"25","author":"S-A Mok","year":"2018","unstructured":"Mok S-A, Condello C, Freilich R et al (2018) Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat Struct Mol Biol 25:384\u2013393. https:\/\/doi.org\/10.1038\/s41594-018-0057-1","journal-title":"Nat Struct Mol Biol"},{"key":"3801_CR95","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40478-020-01079-1","volume":"8","author":"AM Wojtas","year":"2020","unstructured":"Wojtas AM, Carlomagno Y, Sens JP et al (2020) Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation. Acta Neuropathol Commun 8:210. https:\/\/doi.org\/10.1186\/s40478-020-01079-1","journal-title":"Acta Neuropathol Commun"},{"key":"3801_CR96","doi-asserted-by":"publisher","unstructured":"Yuste-Checa P, Trinkaus VA, Riera-Tur I et al (2021) The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model. Nat Commun 12. https:\/\/doi.org\/10.1038\/s41467-021-25060-1","DOI":"10.1038\/s41467-021-25060-1"},{"key":"3801_CR97","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med 284:643\u2013663. https:\/\/doi.org\/10.1111\/joim.12816","journal-title":"J Intern Med"},{"key":"3801_CR98","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","volume":"5","author":"PC May","year":"1990","unstructured":"May PC, Lampert-Etchells M, Johnson SA et al (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer\u2019s disease and in response to experimental lesions in rat. Neuron 5:831\u2013839. https:\/\/doi.org\/10.1016\/0896-6273(90)90342-D","journal-title":"Neuron"},{"key":"3801_CR99","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.neurobiolaging.2005.08.013","volume":"27","author":"T Dunckley","year":"2006","unstructured":"Dunckley T, Beach TG, Ramsey KE et al (2006) Gene expression correlates of neurofibrillary tangles in Alzheimer\u2019s disease. Neurobiol Aging 27:1359\u20131371. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.08.013","journal-title":"Neurobiol Aging"},{"key":"3801_CR100","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF03036452","volume":"7","author":"MD Martin-Rehrmann","year":"2005","unstructured":"Martin-Rehrmann MD, Hoe H-S, Capuani EM, Rebeck GW (2005) Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer\u2019s disease brain. Neurotox Res 7:231\u2013242. https:\/\/doi.org\/10.1007\/BF03036452","journal-title":"Neurotox Res"},{"key":"3801_CR101","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Simmons A, Velayudhan L et al (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67:739\u2013748. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.78","journal-title":"Arch Gen Psychiatry"},{"key":"3801_CR102","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.neuint.2005.12.005","volume":"48","author":"A-M Nilselid","year":"2006","unstructured":"Nilselid A-M, Davidsson P, N\u00e4gga K et al (2006) Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem Int 48:718\u2013728. https:\/\/doi.org\/10.1016\/j.neuint.2005.12.005","journal-title":"Neurochem Int"},{"key":"3801_CR103","doi-asserted-by":"publisher","first-page":"208.e1","DOI":"10.1016\/j.neurobiolaging.2015.09.009","volume":"37","author":"Y Deming","year":"2016","unstructured":"Deming Y, Xia J, Cai Y et al (2016) A potential endophenotype for Alzheimer\u2019s disease: cerebrospinal fluid clusterin. Neurobiol Aging 37:208.e1-208.e9. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.09.009","journal-title":"Neurobiol Aging"},{"key":"3801_CR104","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/NDT.S224877","volume":"16","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang X, Zhu B, Fu P (2020) Association of clusterin levels in cerebrospinal fluid with synaptic degeneration across the Alzheimer\u2019s disease continuum. Neuropsychiatr Dis Treat 16:183\u2013190. https:\/\/doi.org\/10.2147\/NDT.S224877","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3801_CR105","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12660","volume":"29","author":"S Oh","year":"2018","unstructured":"Oh S, Kim MS, Park S et al (2018) Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis. Brain Pathol 29:217\u2013231. https:\/\/doi.org\/10.1111\/bpa.12660","journal-title":"Brain Pathol"},{"key":"3801_CR106","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaneurol.2013.4560","volume":"71","author":"RS Desikan","year":"2014","unstructured":"Desikan RS, Thompson WK, Holland D et al (2014) The role of clusterin in amyloid-\u03b2\u2013associated neurodegeneration. JAMA Neurol 71:180. https:\/\/doi.org\/10.1001\/jamaneurol.2013.4560","journal-title":"JAMA Neurol"},{"key":"3801_CR107","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1210\/clinem\/dgaa378","volume":"105","author":"J Ha","year":"2020","unstructured":"Ha J, Moon MK, Kim H et al (2020) Plasma clusterin as a potential link between diabetes and Alzheimer disease. J Clin Endocrinol Metab 105:3058\u20133068. https:\/\/doi.org\/10.1210\/clinem\/dgaa378","journal-title":"J Clin Endocrinol Metab"},{"key":"3801_CR108","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.2011.381","volume":"305","author":"EMC Schrijvers","year":"2011","unstructured":"Schrijvers EMC, Koudstaal PJ, Hofman A, Breteler MMB (2011) Plasma clusterin and the risk of Alzheimer disease. JAMA 305:1322\u20131326. https:\/\/doi.org\/10.1001\/jama.2011.381","journal-title":"JAMA"},{"key":"3801_CR109","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/bpa.12392","volume":"27","author":"JS Miners","year":"2016","unstructured":"Miners JS, Clarke P, Love S (2016) Clusterin levels are increased in Alzheimer\u2019s disease and influence the regional distribution of A\u03b2. Brain Pathol 27:305\u2013313. https:\/\/doi.org\/10.1111\/bpa.12392","journal-title":"Brain Pathol"},{"key":"3801_CR110","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neurobiolaging.2019.10.025","volume":"89","author":"CE Shepherd","year":"2020","unstructured":"Shepherd CE, Affleck AJ, Bahar AY et al (2020) Intracellular and secreted forms of clusterin are elevated early in Alzheimer\u2019s disease and associate with both A\u03b2 and tau pathology. Neurobiol Aging 89:129\u2013131. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.025","journal-title":"Neurobiol Aging"},{"key":"3801_CR111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11011-018-0325-0","volume":"34","author":"C Yang","year":"2019","unstructured":"Yang C, Wang H, Li C et al (2019) Association between clusterin concentration and dementia: a systematic review and meta-analysis. Metab Brain Dis 34:129\u2013140. https:\/\/doi.org\/10.1007\/s11011-018-0325-0","journal-title":"Metab Brain Dis"},{"key":"3801_CR112","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fneur.2019.00187","volume":"10","author":"J Camacho","year":"2019","unstructured":"Camacho J, Molin\u00e9 T, Bonaterra-Pastra A et al (2019) Brain ApoA-I, ApoJ and ApoE immunodetection in cerebral amyloid angiopathy. Front Neurol 10:187. https:\/\/doi.org\/10.3389\/fneur.2019.00187","journal-title":"Front Neurol"},{"key":"3801_CR113","doi-asserted-by":"publisher","first-page":"e103187","DOI":"10.1371\/journal.pone.0103187","volume":"9","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Hayashi I, Wong J et al (2014) Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein tau in Alzheimer\u2019s disease. PLoS ONE 9:e103187. https:\/\/doi.org\/10.1371\/journal.pone.0103187","journal-title":"PLoS ONE"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03801-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03801-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03801-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:16:21Z","timestamp":1720602981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03801-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3801"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03801-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have agreed to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conset for Publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}